Sentinel Lymph Node Biopsy in Cutaneous Melanoma, a Clinical Point of View

• Published in: Medicina (Kaunas, Lithuania) Vol. 58; no. 11; p. 1589
• Main Authors: Brănişteanu, Daciana Elena, Cozmin, Mihai, Porumb-Andrese, Elena, Brănişteanu, Daniel, Toader, Mihaela Paula, Iosep, Diana, Sinigur, Diana, Brănişteanu, Cătălina Ioana, Brănişteanu, George, Porumb, Vlad, Pînzariu, Alin Constantin, Băilă, Sorin Liviu, Nicolescu, Alin Codruț
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 03.11.2022; MDPI
• Subjects: Biopsy; Cancer therapies; Care and treatment; clinical guidelines; cutaneous melanoma; Diagnosis; Disease; Hematoma; Humans; Localization; Lymph nodes; Lymphatic system; Lymphedema; Medical prognosis; Melanoma; Melanoma - surgery; Melanoma, Cutaneous Malignant; Metastasis; Neoplasm Staging; Practice guidelines (Medicine); Prospective Studies; Review; Risk factors; Sentinel Lymph Node - pathology; sentinel lymph node biopsy; Sentinel Lymph Node Biopsy - methods; Skin cancer; Skin Neoplasms - pathology; Skin Neoplasms - surgery; Romania; clinical guidelines; cutaneous melanoma; sentinel lymph node biopsy
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina58111589

Sentinel lymph node biopsy (SLNB) is a surgical procedure that has been used in patients with cutaneous melanoma for nearly 30 years. It is used for both staging and regional disease control with minimum morbidity, as proven by numerous worldwide prospective studies. It has been incorporated in the recommendations of national and professional guidelines. In this article, we provide a summary of the general information on SLNB in the clinical guidelines for the management of cutaneous malignant melanoma (American Association of Dermatology, European Society of Medical Oncology, National Comprehensive Cancer Network, and Cancer Council Australia) and review the most relevant literature to provide an update on the existing recommendations for SLNB.